Currently, oral administrative drugs commonly used in the treatment of type 2 diabetes mainly include insulin secretion agents (sulfonylurea and glycine secretion), insulin sensitizers (biguanide and gliadin), and alpha-glycosidases[1, 20]. Here, INS is linked to type 2 diabetes mellitus.